Literature DB >> 9259954

Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness.

M Bahuau1, D Vidaud, M Kujas, A Palangié, B Assouline, M Chaignaud-Lebreton, M Prieur, M Vidaud, J P Harpey, J Lafourcade, B Caille.   

Abstract

A five-generation family is here reported in which several members developed malignant melanoma, dysplastic naevi, astrocytoma in all grades, benign or malignant schwannoma, neurofibroma, or meningioma in a single instance. Significant cosegregation of skin and nervous tumours, preclusion of allelism to type 1 neurofibromatosis and phenotypic departure from known syndromes of hereditary proneness to cancer make one suggest an original familial predisposition to both malignant melanoma and central/peripheral nervous tumours.

Entities:  

Mesh：

Year:  1997        PMID： 9259954

Source DB:  PubMed          Journal:  Ann Genet        ISSN： 0003-3995


  8 in total

Review 1.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

2.  Two patients with Hailey-Hailey disease, multiple primary melanomas, and other cancers.

Authors:  Melinda R Mohr; Gulsun Erdag; Amber L Shada; Michael E Williams; Craig L Slingluff; James W Patterson
Journal:  Arch Dermatol       Date:  2011-02

3.  Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma.

Authors:  Maura Massimino; Lorenza Gandola; Roberto Luksch; Filippo Spreafico; Daria Riva; Carlo Solero; Felice Giangaspero; Franco Locatelli; Marta Podda; Fabio Bozzi; Emanuele Pignoli; Paola Collini; Graziella Cefalo; Marco Zecca; Michela Casanova; Andrea Ferrari; Monica Terenziani; Cristina Meazza; Daniela Polastri; Davide Scaramuzza; Fernando Ravagnani; Franca Fossati-Bellani
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

Review 4.  An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.

Authors:  Maria J Baker; Alisa M Goldstein; Patricia L Gordon; Kimberly S Harbaugh; Heath B Mackley; Michael J Glantz; Joseph J Drabick
Journal:  J Med Genet       Date:  2016-01-21       Impact factor: 6.318

5.  Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.

Authors:  C Marian; A Scope; K Laud; E Friedman; F Pavlotsky; E Yakobson; B Bressac-de Paillerets; E Azizi
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

6.  Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history.

Authors:  Andrew K Chan; Seunggu J Han; Winward Choy; Daniah Beleford; Manish K Aghi; Mitchel S Berger; Joseph T Shieh; Andrew W Bollen; Arie Perry; Joanna J Phillips; Nicholas Butowski; David A Solomon
Journal:  Clin Neuropathol       Date:  2017 Sep/Oct       Impact factor: 1.368

7.  Screening of potential novel candidate genes in schwannomatosis patients.

Authors:  Cristina Perez-Becerril; Andrew J Wallace; Helene Schlecht; Naomi L Bowers; Philip T Smith; Carolyn Gokhale; Helen Eaton; Chris Charlton; Rachel Robinson; Ruth S Charlton; D Gareth Evans; Miriam J Smith
Journal:  Hum Mutat       Date:  2022-06-27       Impact factor: 4.700

8.  Brain tumors in patients with myotonic dystrophy: a population-based study.

Authors:  S M Gadalla; R M Pfeiffer; S Y Kristinsson; M Björkholm; O Landgren; M H Greene
Journal:  Eur J Neurol       Date:  2015-10-28       Impact factor: 6.089
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.